IONM · Assure Holdings Corp. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | $229.0K | $475.0K | - | $622.0K | $3.40M | $3.37M | - | $3.69M | $4.00M | $3.88M |
| Gross Profit | ($228.0K) | ($466.0K) | - | ($574.0K) | ($1.86M) | $179.0K | - | $2.52M | ($2.36M) | $824.0K |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $1.16M | $3.91M | - | $3.54M | $3.35M | $3.21M | - | $3.34M | $3.60M | $4.24M |
| Total Operating Expenses | $1.16M | $3.73M | - | $3.63M | $3.60M | $3.52M | - | $3.78M | $4.09M | $4.75M |
| D&A | - | - | - | $5.0K | $181.0K | $184.0K | - | $243.0K | $260.0K | $258.0K |
| Operating Income | ($1.39M) | ($4.20M) | - | ($4.21M) | ($5.46M) | ($3.34M) | - | ($1.26M) | ($6.45M) | ($3.93M) |
| Interest Expense | - | $668.0K | - | $388.0K | $455.0K | $550.0K | - | $324.0K | $123.0K | - |
| Income Tax | - | - | - | - | ($545.0K) | $374.0K | - | ($498.0K) | ($2.30M) | ($337.0K) |
| Net Income | ($255.0K) | ($3.76M) | - | ($7.44M) | ($5.26M) | ($4.31M) | - | ($1.43M) | ($4.73M) | ($2.46M) |
| EPS - Basic | ($0.50) | ($9.72) | - | ($22.14) | ($29.34) | ($73.62) | - | ($32.40) | ($133.20) | ($68.40) |
| EPS - Diluted | ($0.50) | ($9.72) | - | ($22.14) | ($29.34) | ($73.62) | - | ($32.40) | ($133.20) | ($68.40) |
Balance Sheet
| Line item | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $45.0K | $376.0K | $123.0K | $634.0K | $3.15M | $505.0K | $905.0K | $918.0K | $3.96M | $4.08M |
| Accounts Receivable | - | - | $3.60M | - | $9.09M | $12.89M | $15.14M | $20.86M | $20.99M | $26.46M |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - | - | - | - | - |
| Current Assets | $4.64M | $3.73M | $6.72M | $14.34M | $17.90M | $18.59M | $21.39M | $31.63M | $28.89M | $34.63M |
| Total Assets | $5.28M | $4.44M | $7.51M | $15.29M | $20.25M | $21.17M | $24.25M | $43.63M | $40.69M | $44.77M |
| Current Liabilities | $23.79M | $22.75M | $22.22M | $9.59M | $6.89M | $7.20M | $4.97M | $3.65M | $4.36M | $3.71M |
| Long-term Debt | $13.55M | $13.43M | $13.68M | $10.23M | $10.64M | $10.43M | $11.87M | $12.63M | $12.42M | $12.21M |
| Total Liabilities | $23.92M | $23.05M | $22.85M | $21.36M | $18.92M | $19.73M | $18.78M | $17.63M | $18.35M | $17.94M |
| Stockholders' Equity | ($18.64M) | ($18.61M) | ($15.34M) | ($6.07M) | $1.33M | $1.44M | $5.46M | $26.00M | $22.35M | $26.82M |
| Retained Earnings | ($74.25M) | ($74.42M) | ($70.63M) | ($61.57M) | ($54.13M) | ($48.87M) | ($44.56M) | ($23.06M) | ($21.63M) | ($16.90M) |
Cash Flow
| Line item | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | ($1.46M) | - | - | - | ($660.0K) | - | - | - | ($2.32M) |
| Investing Cash Flow | - | $2.32M | - | - | - | ($40.0K) | - | - | - | ($42.0K) |
| Financing Cash Flow | - | ($603.0K) | - | - | - | $300.0K | - | - | - | $4.0K |
| CapEx | - | - | - | - | - | - | - | - | - | $26.0K |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | ($2.35M) |
Ratios
| Metric | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | - | - | - | - | - | - | - | - | - | - |
| EBITDA margin | - | - | - | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - | - | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - | 0.95 |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | - | - | - | - |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | -4.8% | -84.7% | - | -48.6% | -26.0% | -20.4% | - | -3.3% | -11.6% | -5.5% |
| Return on equity | 1.4% | 20.2% | - | 122.6% | -396.2% | -299.4% | - | -5.5% | -21.1% | -9.2% |
| Return on invested capital | - | - | - | - | -36.1% | -22.3% | - | -2.6% | -14.7% | -7.9% |
| Liquidity | ||||||||||
| Current ratio | 0.20 | 0.16 | 0.30 | 1.50 | 2.60 | 2.58 | 4.30 | 8.68 | 6.62 | 9.33 |
| Quick ratio | 0.20 | 0.16 | 0.30 | 1.50 | 2.60 | 2.58 | 4.30 | 8.68 | 6.62 | 9.33 |
| Cash ratio | 0.00 | 0.02 | 0.01 | 0.07 | 0.46 | 0.07 | 0.18 | 0.25 | 0.91 | 1.10 |
| Leverage | ||||||||||
| Debt / Equity | -0.73 | -0.72 | -0.89 | -1.69 | 8.01 | 7.24 | 2.17 | 0.49 | 0.56 | 0.46 |
| Debt / Assets | 2.57 | 3.02 | 1.82 | 0.67 | 0.53 | 0.49 | 0.49 | 0.29 | 0.31 | 0.27 |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | -6.3x | - | -10.8x | -12.0x | -6.1x | - | -3.9x | -52.4x | - |
| Equity multiplier | -0.28 | -0.24 | -0.49 | -2.52 | 15.25 | 14.69 | 4.44 | 1.68 | 1.82 | 1.67 |
| Liabilities / Assets | 4.53 | 5.19 | 3.04 | 1.40 | 0.93 | 0.93 | 0.77 | 0.40 | 0.45 | 0.40 |
| Efficiency | ||||||||||
| Asset turnover | - | - | - | - | - | - | - | - | - | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | 41.6x | 43.7x | - | 134.9x | 303.9x | 936.3x |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | 87.7% | - | - | - | 21.1% | -78.3% | - | -41.3% | 80.0% | -67.5% |
| Operating income growth (YoY) | 74.6% | -25.5% | - | -233.4% | 15.3% | 14.8% | - | - | -340.6% | -1956.0% |
| Net income growth (YoY) | 95.2% | 12.8% | - | -419.1% | -11.3% | -75.4% | - | - | 64.5% | -494.0% |
| EPS growth (YoY) | 98.3% | 86.8% | - | 31.7% | 78.0% | -7.6% | - | - | -34952.6% | -683900.0% |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | -286.0% |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | - | - | - | - | -94.1% | -94.6% | -81.1% | - | -3.8% | 156.2% |
Peer comparison
Same SIC group: Surgical & Medical Instruments & Apparatus
Comparing Assure Holdings Corp. against the 5 most active filers in the same SIC group.